… with the use of biological markers (biomarkers). These provide … biomarkers in the disease
pathogenesis of COVID-19 and … The biomarkers we review include, C-reactive protein (CRP), …

… biomarkers that have shown significant diagnostic and prognostic value for risk stratification
in COVID-19 and … of laboratory biomarkers to easily predict prognosis and outcome in severe …

… Besides, biomarkers can help in reducing the rate of mortality and evaluating viral … of different
biomarkers in the early diagnosis of COVID-19, as well as in the classification of COVID-19 …

… a few biomarkers reliably predict a worse outcome in COVID-19 … This review aims to define
the biological markers that are … been suggested for diagnosis during the COVID-19 pandemic, …

… Therefore, the diagnostic value of eosinopenia in COVID-19 requires further investigation
with larger patient cohorts to establish the sensitivity and specificity of the eosinophil count. …

… shown improved diagnostic accuracy for determining disease severity in patients compared
with single biomarker analyses. Here, we provide a current review of blood/serum biomarker …

… To evaluate association between biomarkers and outcomes in COVID-19 hospitalised
patients. COVID-19 pandemic has been a challenge. Biomarkers have always played an …

… of biomarkers in the diagnosis, prognosis, and treatment of various diseases are also highlighted.
The approaches reported here serve as a guide for biomarker … biomarker qualification. …

… A high neutrophil-to-lymphocyte ratio (NLR) at admission can be a good surrogate
marker for diagnosis of COVID-19. A rising NLR can also be used as a prognostic marker for …

… are caused by COVID-19 on the … COVID-19 be rapidly treated to reduce mortality. Thus,
early measurements of cardiac damage via biomarkers following hospitalization for COVID-19 …